A. Sidney Barritt IV, MD, MSCR, FAASLD, FACG, is a tenured professor at the University of North Carolina. Dr. Barritt is board certified in internal medicine, gastroenterology, and transplant hepatology. He received his medical degree from the University of Virginia School of Medicine in 2002. He completed his internship, residency, and was a chief resident in internal medicine at the University of Alabama-Birmingham. In 2006, Dr. Barritt came to the University of North Carolina as a T32 clinical epidemiology fellow and completed fellowships in gastroenterology and transplant hepatology.
Currently, Dr. Barritt is the Director of Hepatology in the UNC Liver Center and the Transplant Hepatology Fellowship Program Director. Dr. Barritt conducts clinical outcomes research in metabolic dysfunction associated steatotic liver disease (MASLD), general hepatology, and liver transplantation. Dr. Barritt leads the UNC Liver Center’s clinical trial program in MASLD where he is PI on multiple phase 2 and 3 industry sponsored clinical trials and is also a steering committee member for the real-world observational study TARGET-NASH. He is member of the NIH sponsored Drug Induced Liver Injury Network and the PCORI PAL-Liver study. Dr. Barritt is also a founding investigator of SECURE-Liver, an international registry of patients with liver disease and SARS-CoV2 infection. Outside of work, Dr. Barritt enjoys spending time with his family, road running, and triathlons.